Benchmark analyst Bill Sutherland says Healthcare Services Group reported a “noisy” Q2 print that also included positive forward indicators including guidance for a solid uptick in revenue growth in the second half and reiteration of FY24 adjusted operating cash flow guidance. The stock sold off 5% yesterday as investors digested an adjusted EBITDA miss resulting from a non-cash bad debt expense and an adjusted operating cash flow miss due to delayed CMS payments, but the firm views the pullback as a buying opportunity and reiterates its Buy rating and $17 price target on Healthcare Services shares.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HCSG:
- Healthcare Services sees Q3 revenue $425M-$435M, consensus $431.14M
- Healthcare Services reports Q2 EPS (2c), consensus 20c
- Healthcare Services Group (HCSG) Q2 Earnings Cheat Sheet
- Healthcare Services Announces Regulation FD Disclosure Status
- Healthcare Services sees Q2 non-cash charge of roughly 20c from LaVie filing